Drug Trial Radar · NCT05345691
Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis
Last checked: Nov 20, 2026Latest source record: Sep 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
479
Actual
Start
May 24, 2022
Primary completion
Jun 12, 2024
Study completion Jun 12, 2024
Sponsor
- Lead sponsor
- Biocon Biologics UK LtdIndustry
- Sponsor type
- Industry
- First posted
- Apr 26, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 55 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, multicenter, parallel-arm, Phase 3 study to compare the efficacy, PK (Pharmacokinetic), PD (Pharmacodynamic), safety, and immunogenicity of Bmab 1000 and Prolia® in postmenopausal women with osteoporosis
Conditions
- Postmenopausal Women With Osteoporosis
Interventions
Bmab 1000Biological
60 mg administered as a single SC (subcutaneous) injection once every 6 months.
Prolia®Biological
60 mg administered as a single SC injection once every 6 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage Change in Lumbar Spine BMD (Bone Mineral Density)Time frame: Baseline and Week 52
Locations
1 site in 1 country. Site status is shown where the registry gives one.
PPD Global Ltd, Granta Park, Great Abington,
Cambridge, UK, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.